Suppr超能文献

阿尔茨海默病药物 PBT2 与淀粉样β 1-42 肽的相互作用不同于其他 8-羟基喹啉螯合药物。

Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.

机构信息

Molecular and Environmental Sciences Group, Department of Geological Sciences, College of Arts and Science, University of Saskatchewan, 114 Science Place, Saskatoon, SaskatchewanS7N 5E2, Canada.

Department of Chemistry, College of Arts and Science, University of Saskatchewan, 110 Science Place, Saskatoon, SaskatchewanS7N 5C9, Canada.

出版信息

Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8.

Abstract

Although Alzheimer's disease (AD) was first described over a century ago, it remains the leading cause of age-related dementia. Innumerable changes have been linked to the pathology of AD; however, there remains much discord regarding which might be the initial cause of the disease. The "amyloid cascade hypothesis" proposes that the amyloid β (Aβ) peptide is central to disease pathology, which is supported by elevated Aβ levels in the brain before the development of symptoms and correlations of amyloid burden with cognitive impairment. The "metals hypothesis" proposes a role for metal ions such as iron, copper, and zinc in the pathology of AD, which is supported by the accumulation of these metals within amyloid plaques in the brain. Metals have been shown to induce aggregation of Aβ, and metal ion chelators have been shown to reverse this reaction . 8-Hydroxyquinoline-based chelators showed early promise as anti-Alzheimer's drugs. Both 5-chloro-7-iodo-8-hydroxyquinoline (CQ) and 5,7-dichloro-2-[(dimethylamino)methyl]-8-hydroxyquinoline (PBT2) underwent unsuccessful clinical trials for the treatment of AD. To gain insight into the mechanism of action of 8HQs, we have investigated the potential interaction of CQ, PBT2, and 5,7-dibromo-8-hydroxyquinoline (B2Q) with Cu(II)-bound Aβ(1-42) using X-ray absorption spectroscopy (XAS), high energy resolution fluorescence detected (HERFD) XAS, and electron paramagnetic resonance (EPR). By XAS, we found CQ and B2Q sequestered ∼83% of the Cu(II) from Aβ(1-42), whereas PBT2 sequestered only ∼59% of the Cu(II) from Aβ(1-42), suggesting that CQ and B2Q have a higher relative Cu(II) affinity than PBT2. From our EPR, it became clear that PBT2 sequestered Cu(II) from a heterogeneous mixture of Cu(II)Aβ(1-42) species in solution, leaving a single Cu(II)Aβ(1-42) species. It follows that the Cu(II) site in this Cu(II)Aβ(1-42) species is inaccessible to PBT2 and may be less solvent-exposed than in other Cu(II)Aβ(1-42) species. We found no evidence to suggest that these 8HQs form ternary complexes with Cu(II)Aβ(1-42).

摘要

尽管阿尔茨海默病(AD)在一个多世纪前就已被首次描述,但它仍是与年龄相关的痴呆症的主要原因。无数的变化与 AD 的病理学有关;然而,对于哪种变化可能是疾病的最初原因,仍然存在很大的争议。“淀粉样蛋白级联假说”提出,淀粉样β(Aβ)肽是疾病病理学的核心,这一假说得到了在出现症状之前大脑中 Aβ水平升高以及淀粉样斑块中的淀粉样蛋白负荷与认知障碍的相关性的支持。“金属假说”提出,铁、铜和锌等金属离子在 AD 的病理学中起作用,这一假说得到了大脑中淀粉样斑块内这些金属的积累的支持。已经表明金属可以诱导 Aβ聚集,并且金属离子螯合剂已被证明可以逆转这种反应。基于 8-羟基喹啉的螯合剂作为抗阿尔茨海默病药物显示出早期的希望。5-氯-7-碘-8-羟基喹啉(CQ)和 5,7-二氯-2-[(二甲基氨基)甲基]-8-羟基喹啉(PBT2)均因治疗 AD 的临床试验失败而未被采用。为了深入了解 8HQ 的作用机制,我们使用 X 射线吸收光谱(XAS)、高能分辨荧光探测(HERFD)XAS 和电子顺磁共振(EPR)研究了 CQ、PBT2 和 5,7-二溴-8-羟基喹啉(B2Q)与 Cu(II)结合的 Aβ(1-42)之间的潜在相互作用。通过 XAS,我们发现 CQ 和 B2Q 从 Aβ(1-42)中螯合了约 83%的 Cu(II),而 PBT2 仅从 Aβ(1-42)中螯合了约 59%的 Cu(II),这表明 CQ 和 B2Q 对 Cu(II)的亲和力比 PBT2 高。从我们的 EPR 中可以清楚地看出,PBT2 从溶液中 Cu(II)-Aβ(1-42)的异构混合物中螯合 Cu(II),留下单一的 Cu(II)-Aβ(1-42)物种。因此,该 Cu(II)-Aβ(1-42)物种中的 Cu(II)位点对 PBT2 不可访问,并且比其他 Cu(II)-Aβ(1-42)物种中的 Cu(II)位点更不易受溶剂影响。我们没有发现这些 8HQ 与 Cu(II)-Aβ(1-42)形成三元配合物的证据。

相似文献

1
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8.
5
Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Biometals. 2017 Apr;30(2):285-293. doi: 10.1007/s10534-017-0005-2. Epub 2017 Mar 10.
6
Solution Chemistry of Copper(II) Binding to Substituted 8-Hydroxyquinolines.
Inorg Chem. 2020 Oct 5;59(19):13858-13874. doi: 10.1021/acs.inorgchem.0c01356. Epub 2020 Sep 16.
7
Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Acc Chem Res. 2012 Sep 18;45(9):1604-11. doi: 10.1021/ar300074t. Epub 2012 Jun 29.
8
8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.
J Inorg Biochem. 2014 Oct;139:106-16. doi: 10.1016/j.jinorgbio.2014.04.011. Epub 2014 Apr 28.
10
X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.
Inorg Chem. 2019 May 6;58(9):6294-6311. doi: 10.1021/acs.inorgchem.9b00507. Epub 2019 Apr 23.

引用本文的文献

1
Novel Copper Chelators Enhance Spatial Memory and Biochemical Outcomes in Alzheimer's Disease Model.
ACS Chem Neurosci. 2025 Sep 3;16(17):3267-3281. doi: 10.1021/acschemneuro.5c00291. Epub 2025 Aug 15.
2
Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans.
Dis Model Mech. 2025 Jul 1;18(7). doi: 10.1242/dmm.052230. Epub 2025 Jul 25.
3
Crosstalk between copper, Alzheimer's disease, and melatonin.
Biometals. 2025 Jul 12. doi: 10.1007/s10534-025-00712-7.
5
Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.
ACS Omega. 2025 Feb 3;10(6):5148-5171. doi: 10.1021/acsomega.4c05527. eCollection 2025 Feb 18.
7
Metal Ion Signaling in Biomedicine.
Chem Rev. 2025 Jan 22;125(2):660-744. doi: 10.1021/acs.chemrev.4c00577. Epub 2025 Jan 2.
8
Copper homeostasis and neurodegenerative diseases.
Neural Regen Res. 2025 Nov 1;20(11):3124-3143. doi: 10.4103/NRR.NRR-D-24-00642. Epub 2024 Nov 13.
10
Copper and cuproptosis: new therapeutic approaches for Alzheimer's disease.
Front Aging Neurosci. 2023 Dec 19;15:1300405. doi: 10.3389/fnagi.2023.1300405. eCollection 2023.

本文引用的文献

2
Transient disorder along pathways to amyloid.
Biophys Chem. 2022 Feb;281:106711. doi: 10.1016/j.bpc.2021.106711. Epub 2021 Oct 30.
3
Disorder-to-order transition of the amyloid-β peptide upon lipid binding.
Biophys Chem. 2022 Jan;280:106700. doi: 10.1016/j.bpc.2021.106700. Epub 2021 Oct 26.
6
Solution Chemistry of Copper(II) Binding to Substituted 8-Hydroxyquinolines.
Inorg Chem. 2020 Oct 5;59(19):13858-13874. doi: 10.1021/acs.inorgchem.0c01356. Epub 2020 Sep 16.
7
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
J Alzheimers Dis. 2021;82(s1):S335-S357. doi: 10.3233/JAD-200185.
9
High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.
Chem Commun (Camb). 2020 Apr 30;56(34):4627-4639. doi: 10.1039/d0cc01551b. Epub 2020 Apr 17.
10
β-Amyloid aggregation and heterogeneous nucleation.
Protein Sci. 2019 Sep;28(9):1567-1581. doi: 10.1002/pro.3674. Epub 2019 Aug 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验